Department of Surgery (General Thoracic Surgery)

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Lung 50%
3. Adenocarcinoma of Lung 49%
4. Neoplasms 46%
5. Non-Small Cell Lung Carcinoma 46%
6. Neoplasm Staging 43%
7. Survival 31%
8. Segmental Mastectomy 28%
9. Neoplasm Metastasis 25%
10. Thymoma 22%
11. Recurrence 20%
12. Databases 17%
13. Adenocarcinoma 17%
14. Glass 16%
15. Tomography 15%
16. Japan 14%
17. Thymic epithelial tumor 12%
18. Adenocarcinoma in Situ 12%
19. Cryosurgery 12%
20. Metastasectomy 12%
21. Medical Oncology 11%
22. Mutation 10%
23. Lymph Nodes 10%
24. Registries 10%
25. Adjuvant Chemotherapy 10%
26. Cancer-Associated Fibroblasts 10%
27. Thorax 10%
28. Survival Rate 9%
29. Therapeutics 9%
30. Malignant Mesothelioma 8%
31. Clinical Trials 8%
32. Propensity Score 8%
33. Dissection 8%
34. Mesothelioma 7%
35. Margins of Excision 7%
36. Safety 6%
37. Colorectal Neoplasms 6%
38. Pneumothorax 6%
39. Lymph Node Excision 6%
40. Lovastatin 6%
41. Multicenter Studies 6%
42. Tumor Microenvironment 5%
43. Needle Biopsy 5%
44. Idiopathic Pulmonary Fibrosis 5%
45. Carcinoma 5%
46. Trachea 5%
47. Chest Tubes 5%
48. Myasthenia Gravis 5%
49. Retrospective Studies 5%
50. Carcinoid Tumor 5%
51. Radiotherapy 5%
52. Confidence Intervals 5%